Abstract
Cyproterone acetate is a powerful antiandrogen used in the treatment of the paraphilias for at least a decade. Studies have reported it effective in reducing the recidivism rates of sexual crimes perpetrated by men. It acts through competitive inhibition of the androgen receptors blocking the effects of testosterone and dihydrotestosterone. Systematic clinical study of its effectiveness and its clinical effects on sexual behavior is lacking, however. In the current study 19 paraphilic men who had also recidivated in a variety of sexual crimes were treated with cyproterone acetate and placebo in a double-blind crossover design. The use of active drug was associated with a significant reduction of some aspects of sexual behavior, particularly sexual fantasies. There were also significant effects on levels of circulating sex hormones and some effects on physiological measurements and self-reports of sexual arousal.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abel, G. G., Becker, J. V., and Skinner, L. J. (1980). Aggressive behaviour and sex.Psychiat. Clin. N. Am. 3: 133.
Abel, G. G., Becker, J. V., and Skinner, L. J. (1983). Treatment of the violent sex offender. In Roth, L. H. (ed.),Clinical Treatment of the Violent Person. Crime and Delinquency Issues, National Institute of Mental Health Monograph Series, Bethesda, MD.
Abel, G. G., Mittelman, M. S., and Becker, J. V. (1984). Sexual offenders: Results of assessments and recommendations for treatment. In Ben-Aron, M. H., Hucker, S. J., and Webster, C. D. (eds..),Clinical Criminology: The Assessment and Treatment of Criminal Behaviour M & M Graphics, Toronto.
American Psychiatric Association. (1987).Diagnostic and Statistical Manual of Mental Disorders 3rd. ed., rev., APA, Washington, DC, pp. 261–285.
Appelt, M., and Floru, L. (1974). Erfahrungen uber die Beeinflussung der Sexualitat durch Cyproteronacetat (“Androcur,” Schering).Int. Pharmacopsychiat. 9:61.
Bancroft, J. (1983).Human Sexuality and Its Problems Churchill Livingstone, New York, pp. 145–152.
Bancroft, J. (1988). Reproductive hormones and male sexual function. In Sitsen, J. M. A. (ed.),The Pharmacology and Endocrinology of Sexual Function, Handbook of Sexology, Vol. 6, Elsevier, Amsterdam, pp. 297–316.
Bancroft, J. (1989).Human Sexuality and Its Problems 2nd ed., Churchill Livingstone, New York. pp 12–146.
Bancroft, J., Tennent, T. G., Loucas, K., and Cass, J. (1974). Control of deviant sexual behaviours of drugs: Behavioural changes following oestrogens and antiandrogens.Br. J. Psychiat. 125: 310.
Baron, D. P., and Unger, H. R. (1977). A clinical trial of Cyproterone acetate for sexual deviancy.New Engl. J. Med. 85: 366.
Berner, W., Brownstone, G., and Sluga, W. (1983). The Cyproteronacetat treatment of sexual offenders.Neurosci. Biobehav. Rev. 7: 441.
Bradford, J. M. W. (1979)Forensic Psychiatric Questionnaire. Unpublished Document; copyright J. Bradford.
Bradford, J. M. W. (1983a). Research on sex offenders: Recent trends.Psychiat. Clin. N. Am. 6: 715–731.
Bradford, J. M. W. (1983b). Hormonal treatment of sexual offenders.Bull. Am. Acad. Psychiat. Law 11: 159–169.
Bradford, J. M. W. (1984). The psychiatric evaluation of the sexual offender.Newsletter, Am. Acad. Psychiat. Law 9: 18–19.
Bradford, J. M. W. (1985). Organic treatments for the male sexual offender.Behav. Sci. Law 3: 355–375.
Bradford, J. M. W. (1988). Treatment of sexual offenders with cyproterone acetate. In Sitsen, J. M. A. (ed.),Handbook of Sexology: The Pharmacology and Endocrinology of Sexual Function, Vol. 6, Elsevier, Amsterdam, pp. 526–536.
Bradford, J. M. W., and Pawlak, A. (1987). Sadistic homosexual pedophilia: Treatment with cyproterone acetate: A single case study.Can J. Psychiat. 32: 22–30.
Buss, A. H., and Durkee, A. (1957). An inventory for assessing different kinds of hostility.J. Consult. Psychol. 21: 343–349.
Cooper, A. J. (1981). A placebo controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality.Comprehen. Psychiat. 22: 458.
Cooper, A. J., Ismail, A. A., Phanjoo, A. L., and Love, D. L. (1972). Antiandrogen (cyproterone acetate) therapy in deviant hypersexuality.B. J. Psychiat. 120: 59.
Davies, T. S. (1974). Cyproterone acetate for male hypersexuality.J. Int. Med. Res. 2: 159.
Fahndrich, E. (1974). Cyproteronacetat in der Behandlung von Sexual deviationen, bei Mannern.Deut. Med. Wochschr. 99: 234.
Freund, K. (1980). Therapeutic sex drive reduction.Acta Psychiat. Scand. 62: 5–38.
Gebhard, P. H., Gagnon, J. H., Pomeroy, W. B., and Christenson, C. V. (1965).Sex Offenders: An Analysis of Types Harper and Row, New York, pp. 811–812.
Halleck, S. L. (1981). The ethics of antiandrogen therapy.Am. J. Psychiat. 138: 642–643.
Horn, J. H. (1972). Die Behandlung von Sexual Delinquenten mit Cyproteronacetat.Life Sci. Monogr. 2: 113.
Jost, F. (1974). Klinische Beobachtungen und Erfahrungen in der Behandlung Sexueller Deviationen mit dem Antiandrogen Cyproterone-Acetat.Schweiz. Rundschau. Med. (Praxis) 63: 1318.
Jost, F. (1975). Zur Behandlung Abnormen Sexualverhaltens mit dem Antiandrogen Cyproteronacetat, Der Informierte.ARZT 3: 303.
Laschet, U. (1973). Antiandrogen in the treatment of sexual offenders: Mode of action and therapeutic outcome. In Zubin, J., and Money, J. (eds.),Contemporary Sexual Behaviours: Critical Issues in the 1970's Johns Hopkins Press, Baltimore, MD, p. 311.
Laschet, U., and Laschet, L. (1971). Psychopharmacotherapy of sex offenders with cyproterone acetate.Pharmakopsychiat. Neuropsychopharmakol. Adv. Clin. Res. 4: 99.
Laschet, U., and Laschet, L. (1975). Antiandrogens in the treatment of sexual deviations of men.J. Steroid Biochem. 6: 821.
Minister of Supply and Services Canada. (1984). Report of the Committee on Sexual Offences Against Children and Youths: Sexual Offences Against Children in Canada, Vol. I, II, and Summary.
Mothes, C., Lehnert, J., Samimi, F., and Ufer, J. (1971). Schering Symposium Uber Sexual Deviationen und Ihre Medikamentose Behandlung, Pergamon, Oxford.
Murray, M. A., Bancroft, J., Anderson, D. C., Tennent, T. G., and Carr, R. J. (1975). Endocrine changes in male sexual deviants after treatment with antiandrogens, oestrogens, or tranquilizers.J. Endocrinol. 67: 179.
Neumann, F., Graf, K. J., Hasam, S. H., Schewck, B., and Steinbeck, H. (1977). Central actions of antiandrogens. In Martini, L., and Motta, M. (eds.),Androgens and Antiandrogens Raven, New York, pp. 163–177.
Neumann, F., and Schleusener, A. (1980). Pharmacology of cyproterone acetate with special reference to the skin. In Vokoer, R., and Fanta, D. (Eds.),The Pharmacology of Cyproterone Acetate, Combined Antiandrogen-Estrogen Therapy in Dermatology, Proceedings of Dianne Symposium, Brussels, pp. 19–51.
Neumann, F., and Von Berswordt-Wallrabe, R. (1966). Effects of the of the androgen antagonist cyproterone acetate on the testicular structure: Spermiogenesis and accessory sexual glands of testosterone treated hypophysectomized rats.J. Endocrinol. 35: 363–367.
Neumann, F., Von Berswordt-Wallrabe, R., Eiger, W., Steinbeck, H., Hahn, J. D., and Kramer, M. (1970). Aspects on androgen dependent events as studied by antiandrogens.Recent Prog. Horm. Res. 26: 227–342.
Ortman, J. (1980). The treatment of sexual offenders: Castration and antihormone therapy.Int. J. Law Psychiat. 3: 443–451.
Ott, F., and Hoffet, H. (1968). The influence of antiandrogens on libido, potency and testicular function.Schweiz. Med. Wochschr. 98: 1812.
Overall, J. E., and Gorham, D. R. (1962). The Brief Psychiatric Rating Scale.Psychol. Rep. 10: 799–812.
Rand, M. J., and Nott, M. W. (1988). Basic neuropharmacology in sexology. In Sitsen, J. M. A. (ed.),The Pharmacology and Endocrinology of Sexual Function, Vol. 6, Elsevier, Amsterdam, 1–32.
Radzinowicz, L. (1957).Sexual Offences: A Report of the Cambridge Department of Criminal Science MacMillan, London, pp. 156–157.
Rausch-Stroomann, J. G., Petry, R., Hocevar, V., Mauss, J., and Senge, T. (1970). Influence of an antiandrogen (cyproterone) on the gonadotrophic function of the pituitary gland on the gonads, and on metabolism in normal men.Acta Endocrinol. 63: 595–608.
Schering, A. G. (1983).Androcur Berlin/Bergkamen, Berlin, Germany.
Soothill, K. L., and Gibbens, T. C. N. (1978). Recidivism of sexual offenders: Reappraisal.Br. J. Criminol. 18: 267–275.
Statistics Canada. (1982).Uniform Crime Reporting Statistics Canada and the Provinces 1977–1981, Sexual Offences. Canadian Centre for Justice Statistics, Ottawa.
Tennent, G., Bancroft, J., and Cass, J. (1974). The control of deviant sexual behavior by drugs: A double-blind controlled study of benperidor, chrorpromatine and placebo.Arch. of Sex. Behav. 3: 261–271.
Woodbury, J., and Schwart, E. (1971).The Silent Sin New American Library, New York.
Zbytovsky, J., and Zapletalek, M. (1979). Cyproteroneacetate in the therapy of sexual deviations.Activatis Nervosa Super. (Praha) 21: 162.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bradford, J.M.W., Pawlak, A. Double-blind placebo crossover study of cyproterone acetate in the treatment of the paraphilias. Arch Sex Behav 22, 383–402 (1993). https://doi.org/10.1007/BF01542555
Issue Date:
DOI: https://doi.org/10.1007/BF01542555